Postoperative Pain After Ambulatory Surgery: Clinical Trials

2 trials for Postoperative Pain After Ambulatory Surgery, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Not yet recruiting 1

Follow Postoperative Pain After Ambulatory Surgery: new trials by email Literature Review of Postoperative Pain After Ambulatory Surgery trials Research Report on Postoperative Pain After Ambulatory Surgery

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Post-Operative Spinal Block Duration and Pain Relief After Hip Replacement Surgery: Comparing Single-Shot Spinal Ropivacaine and Bupivacaine
Spinal Anesthesia with Ropivacaine 15 mg (5 mg/ml), Spinal Anesthesia with Bupivacaine 11 mg (5 mg/ml) - Hip Osteoarthritis, Hip Arthroplasty Replacement
Phase 4Not yet recruitingUniversity of Turku1762026-06-012026-06-05
Controlled-Release Oxycodone Versus Naproxen at Home After Ambulatory Surgery: A Randomized Controlled Trial
PCM/Oxy1, PCM/Oxy2 - Postoperative Pain After Ambulatory Surgery
Phase 4CompletedMaastricht University Medical Center1052007-10-012014-06-02

Narrower conditions

Osteoarthritis, Hip (1)  ·  Pain, Postoperative (1)

Broader conditions

Arthritis (1)  ·  Joint Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Neurologic Manifestations (1)  ·  Osteoarthritis (1)  ·  Pain (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Postoperative Complications (1)  ·  Rheumatic Diseases (1)  ·  Signs and Symptoms (1)

Interventions

Anesthesia, Spinal (1)  ·  Bupivacaine (1)  ·  Ropivacaine (1)

Sponsors

Maastricht University Medical Center (1)  ·  University of Turku (1)

Countries

Netherlands (1)

Top investigators

Panu Uusalo, MD, PhD (1)

Results publications

PMID 25516773

NIH funding

2025 (1)